An Efficient Bioconjugation Technology for Site-Selective Covalent Modification of Antibodies using an Engineered Affinity Peptide
Invention type: Technology
/
Case number: #25358
Researchers
Bradley Pentelute
/ Andrei Ioan Loas
/ Jacob Rodriguez
/ Heemal Dhanjee
/ Aurelie Rondon
/ Katsushi Kitahara
Departments: Department of Chemistry
Technology Areas: Biotechnology: Synthetic Biology / Therapeutics: Proteins & Antibodies, Small Molecules
Impact Areas: Healthy Living
-
site-selective conjugation of a pharmaceutical agent to an antibody using an affinity peptide
United States of America | Pending
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.